Evidence map›Paper›PMID 30886657›Full record

ArticleDisease markers2019

Oxidative Stress in Animal Models of Acute and Chronic Renal Failure.

Marianna Gyurászová, Alexandra Gaál Kovalčíková, Emese Renczés, Katarína Kmeťová, Peter Celec, Janka Bábíčková, Ľubomíra Tóthová

Open access · hybridAbstract read
In one paragraph

Article in Disease markers, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. The nephrotoxicity ofHeliyon · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Therapeutic Implications of Ferroptosis in Renal Fibrosis.Frontiers in molecular biosciences · 2022
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Acute Kidney Injury and Pediatric Bone Health.Frontiers in pediatrics · 2020
    Review
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Marianna GyurászováInstitute of Molecular Biomedicine, Faculty of Medicine, Comenius University, Bratislava, Slovakia.
Alexandra Gaál KovalčíkováInstitute of Molecular Biomedicine, Faculty of Medicine, Comenius University, Bratislava, Slovakia.
Emese RenczésInstitute of Molecular Biomedicine, Faculty of Medicine, Comenius University, Bratislava, Slovakia.ORCID 0000-0003-2667-636X
Katarína KmeťováInstitute of Molecular Biomedicine, Faculty of Medicine, Comenius University, Bratislava, Slovakia.
Peter CelecInstitute of Molecular Biomedicine, Faculty of Medicine, Comenius University, Bratislava, Slovakia.ORCID 0000-0001-5883-3580
Janka BábíčkováInstitute of Molecular Biomedicine, Faculty of Medicine, Comenius University, Bratislava, Slovakia.ORCID 0000-0001-7859-9242
Ľubomíra TóthováInstitute of Molecular Biomedicine, Faculty of Medicine, Comenius University, Bratislava, Slovakia.ORCID 0000-0001-9162-4916
Comenius University Bratislava · SKUniversity of Bergen · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionKidney disease is a worldwide health and economic burden, with rising prevalence. The search for biomarkers for earlier and more effective disease screening and monitoring is needed. Oxidative stress has been linked to both, acute kidney injury (AKI) and chronic kidney disease (CKD). The aim of our study was to investigate whether the concentrations of systemic markers of oxidative stress and antioxidant status are affected by AKI and CKD, and to identify potential biomarkers.

methodsIn adult male Wistar rats, AKI was induced by bilateral nephrectomy, and CKD was induced by 5/6 nephrectomy. Blood was collected 48 hours after surgery in AKI and 6 months after surgery in CKD. Advanced oxidation protein products (AOPP), thiobarbituric acid reactive substances (TBARS), advanced glycation end products (AGEs), fructosamine, total antioxidant capacity (TAC), and ferric reducing antioxidant power (FRAP) were measured.

resultsImpaired renal function was confirmed by high concentrations of plasma creatinine and urea in AKI and CKD animals. AOPP and fructosamine were higher by 100% and 54% in AKI, respectively, and by 100% and 199% in CKD, respectively, when compared to corresponding control groups. Similarly, there was approximately a twofold increase in AGEs (by 92%) and TAC (by 102%) during AKI. In CKD, concentrations of FRAP, as an antioxidative status marker, were doubled (by 107%) when compared to the control group, but concentration of TAC, another marker of antioxidative status, did not differ between the groups.

conclusionsAKI and CKD led to increased systemic oxidative stress. AOPP and fructosamine could be considered potential biomarkers for both, acute and chronic kidney damage. On the other hand, AGEs, TAC, and FRAP seem to be disease specific, which could help to differentiate between acute and chronic kidney injuries. However, this needs further validation in clinical studies.

Indexed as

Oxidative StressAcute Kidney InjuryAnimalsFructosamineGlycation End Products, AdvancedMaleRatsRats, WistarRenal Insufficiency, ChronicThiobarbituric Acid Reactive SubstancesFructosamineGlycation End Products, AdvancedThiobarbituric Acid Reactive Substances

Identifiers

PMID30886657
PMCPMC6388331
OpenAlexW2911751483

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.